<
Ali Health Turn to Ying Tmall Medical Commodity Transactions exceeds 25 billion yuan
Release time: 2018-12-06 & nbsp & nbsp & nbsp Source: Anonymous

Recently,Alibaba Health Release as of September 30, 2018,Revenue increased by 111.2%year -on -year to 1.879 billion yuan,gross profit increased by 107.1%year -on -year to 529 million yuan,Adjusted net profit of 10.5 million yuan,Compared with the same period last year, it achieved a turnover into a profit。Shareholders should narrow the loss stake betting appby 7.Stake Sports Betting5%year -on -year to 84.104 million yuan,Losses per share 0.8 points。

It is reported,Ali Health Pharmaceutical's self -operating business continues to maintain strong growth,Revenue reaches 1.601 billion yuan,increased by 100.2%year -on -year。Online self -operated store as of September 30, 2018,12 months of annual active consumers (consumers who actually purchased products once and above on the platform in the past 12 months) exceeded 18 million。Ali's healthy high -speed development online business,Also actively deployed offline pharmaceutical retail market,and continuously explore the development path of new retail in pharmaceuticals。

Announcement name,The strong growth of income and gross profit is mainly due to the rapid growth of pharmaceutical self -operating business and pharmaceutical e -commerce platform business。The net cash flow of business activities has also improved significantly,reached 302 million yuan。After adjustment, the profitable profit is mainly due to the rapid growth of the medical self -employment business and the pharmaceutical e -commerce platform service business,At the same time, the consumer medical business has also begun Stake Sports Bettingto stake online sports bettingcontribute profit。Ali Health's continuous enhancement in profitability,will help continue to invest in medical big data in the future、Medical Artificial Intelligence (AI) and other related fields,Increase the investment and layout of innovative businesses such as Internet medical and smart medical care。

Alibaba Health has further acquired from Alibaba Group the medical device and health supplies、Adult Family Plan、contact lenses、Medical and Health Service E -commerce Platform Business,and start to provide outsourcing and value -added services for the Tmall platform nourishing health category。During the reporting period,The total amount of commodity transactions (GMV) generated by the Tmall pharmaceutical e -commerce platform operated by the group exceeds 25 billion yuan,increased by more than 50%year -on -year。As of September 30, 2018,The annual active consumers of Tmall Medical Museum of 12 months have exceeded 100 million。

In September 2018,Ali Health via Alipay、Taobao and other platforms provide more than 1 million dates including payment、Registration、Medical and Health Service, including online health consultation。The Group has further strengthened stake sports betting appin stake sports betting app-depth cooperation with Ant Financial after the reporting period,and signed a strategic cooperation agreement with Alipay, a wholly -owned subsidiary of Ant Financial in November 2018。

Based on this,Ali Health will set up an independent medical and health service channel on the Alipay client in the future,Responsible for fully managing the medical and health business in the channel and industry partners。As of September 30, 2018,Alipay has signed more than 6,500 medical institutions,Among them, there are more than 2000 in the second and third -level hospitals。

In addition,Alibaba Health Coordinates the high -quality resources inside and outside the Alibaba Group during the reporting period,Continue to create a medical AI system with actual application scenarios。September 2018,Group and Alibaba Cloud announced the construction of Ali Medical Artificial Intelligence System, that is, ET Medical Brain 2.0。October 2018,Group and Beijing Science and Technology Commission announced the establishment of the country's first medical AI open innovation application platform,At the same time, the third party artificial intelligence open platform for the medical AI industry was launched。